Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2012 Oct 25;13(1):48–54. doi: 10.1016/j.clml.2012.07.009

Figure 4. Combination of Tests Used to Monitor Initial Response to Oral Tyrosine Kinase Inhibitor Therapy (Question 15). Multiple Answers were Allowed.

Figure 4

Abbreviations: BC = bone marrow cytogenetics; BF = bone marrow FISH; FISH = fluorescence in situ hybridization; M = breakpoint cluster region-abelson (BCR-ABL) kinase domain mutation analysis; PC = peripheral blood cell count; PF = peripheral blood FISH; Q = quantitative reverse-transcriptase polymerase chain reaction.